Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2 2

Status

Completed 11Unknown 4Terminated 3Recruiting 2Withdrawn 1Not yet recruiting 1

Sponsor Class

NIH 4

Study Type

Interventional 4

Sponsor

Cancer Type

CNS 4Sarcoma 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Leukemia 15Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Lymphoma, Non-Hodgkin 8Lymphoma 8Leukemia, Myeloid, Acute 8Multiple Myeloma 6Myelodysplastic Syndromes 5Lymphoma, Large B-Cell, Diffuse 5Leukemia, Myeloid, Chronic-Phase 5Neuroblastoma 4Hodgkin Disease 4Graft vs Host Disease 4Congenital Abnormalities 4Recurrence 3Neoplasms, Plasma Cell 3Lymphoma, Mantle-Cell 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, Follicular 3Leukemia, Myelomonocytic, Juvenile 3Leukemia, Lymphocytic, Chronic, B-Cell 3Burkitt Lymphoma 3Sarcoma 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Neuroectodermal Tumors, Primitive, Peripheral 2Lymphoma, Large-Cell, Anaplastic 2Lymphoma, Extranodal NK-T-Cell 2Lymphoma, B-Cell, Marginal Zone 2Leukemia, Myelomonocytic, Acute 2Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2Leukemia, Myeloid, Accelerated Phase 2

Interventions

Cyclophosphamide 12Vincristine 10Radiotherapy 10Carboplatin 10Cisplatin 8Melphalan 7Etoposide 73-Iodobenzylguanidine 7Isotretinoin 6Filgrastim 6Doxorubicin 6aldesleukin 4Peripheral Blood Stem Cell Transplantation 4Busulfan 4etoposide phosphate 3Topotecan 3Neoadjuvant Therapy 3Interleukin-2 3Ifosfamide 3fludarabine 2dinutuximab 2Vindesine 2Polymerase Chain Reaction 2Granulocyte-Macrophage Colony-Stimulating Factor 2Dacarbazine 2Chemotherapy, Adjuvant 2sargramostim 1irinotecan sucrosofate 1ganglioside, GD2 1fludarabine phosphate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × Neuroblastoma × Busulfan × Clear all
NCT00030719 2014-06-24

Combination Chemotherapy With or Without Filgrastim Before Surgery, High-Dose Chemotherapy, and Radiation Therapy Followed by Isotretinoin With or Without Monoclonal Antibody in Treating Patients With Neuroblastoma

National Cancer Institute (NCI)

Phase 3 Unknown
175 enrolled
CNS

Neuroblastoma

NCT00084695 2014-01-10

Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant Diseases

National Cancer Institute (NCI)

Phase 2 Unknown
25 enrolled
CNSClassical hematologyLymphoidMyeloidOther hematologic neoplasmSarcoma

Burkitt Lymphoma, Fanconi Anemia, Leukemia, Lymphoma, Myelodysplastic Syndromes, Neuroblastoma, Recurrence, Sarcoma, Leukemia, Myeloid, Chronic-Phase, Neuroectodermal Tumors, Primitive, Peripheral, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myelomonocytic, Juvenile, Dendritic Cell Sarcoma, Interdigitating

NCT00024193 2013-08-07

Chemotherapy and Surgery Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Neuroblastoma

National Cancer Institute (NCI)

Phase 2 Unknown
CNS

Neuroblastoma

NCT00417053 2013-08-02

Combination Chemotherapy in Treating Infants With Newly Diagnosed Neuroblastoma Who Are Undergoing Surgery With or Without Autologous Bone Marrow or Peripheral Stem Cell Transplant

National Cancer Institute (NCI)

Phase 3 Unknown
CNS

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡